Current filters:  
Healthcare
China
DeHeng Law Offices
2020年1月30日,国家卫健委疾病预防控制局发布《预防新型冠状病毒感染的肺炎口罩使用指南》,明确口罩是预防呼吸道传染病的重要防线,可以ƀ
UK
Cooley LLP
The update provides further clarity on the UK's status in the licensing process now that Brexit has taken place.
Arnold & Porter
The UK government published its Medicines and Medical Devices Bill (the Bill) on 13 February 2020.
McCarthy Tétrault LLP
On February 13, 2020, the UK's Food Standards Agency (the "FSA") updated its business guidance on how it intends to regulate products for consumption containing cannabidiol ("CBD").
United Arab Emirates
STA Law Firm
The Cabinet Resolution No. 40 of 2019 related to Federal law No. 4 of 2016 i.e. Medical Liability Law was issued to elaborate the implementation machinery of the law.
United States
Buchanan Ingersoll & Rooney PC
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters
Foley Hoag LLP
The Centers for Medicare & Medicaid Services (CMS) suffered a big loss in court last week. The United States Court of Appeals for the D.C. Circuit upheld a lower...
Hogan Lovells
The U.S. Food and Drug Administration (FDA) has released the third and final installment of its Draft Guidance to support compliance with the Mitigation...
Foley & Lardner
How are businesses across the health care and life sciences spectrum collaborating to capitalize on the commercial promise of personalized medicine.
Reed Smith
This is a quick-hit post bringing you two first-of-their-kind orders on proving causation in cases alleging inadequate drug or medical device warnings.
Reed Smith
We've discussed before how we expect genetic testing of plaintiffs to become routine in prescription medical product liability litigation.
McDermott Will & Emery
When it comes to market success for digital tools in the health sector, business strategy can be far more complex than in other industries.
BakerHostetler
FDA and CDC Announced the End of a Salmonella Outbreak in Fresh Fruit – The Food & Drug Administration (FDA) completed its investigation
Ogletree, Deakins, Nash, Smoak & Stewart
In August of 2019, HHS issued guidance stating that it would not enforce the April final rule until new guidance was issued.
Sheppard Mullin Richter & Hampton
As women in professional industries such as finance, healthcare, and law continue to make strides in breaking down barriers, there still remains great gender disparity when examining the leadership
Reed Smith
The Department of Health and Human Services (HHS) has modified HIPAA retail pharmacy transaction requirements to differentiate between partial fill ...
Reed Smith
The Centers for Medicare & Medicaid Services (CMS) has proposed updates to its standards for health plan issuers offering plans ...
Reed Smith
We've brought you some great news from the gadolinium contrast agent litigation last year and the hits just keeping on coming.
Foley & Lardner
Federal and state legislatures have taken note of the nationwide opioid crisis and recently responded with legislative attempts to—among instituting other legal changes...
Reed Smith
CMS has put on display a proposed rule that would update Medicare Advantage (MA) and Medicare Part D prescription drug benefit policies for contract year 2021 and 2022.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media